FDx Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-753
| Closed | -$243K | – | 380 |
|
|
2023
Q4 | $243K | Buy |
753
+155
| +26% | +$50K | 0.02% | 596 |
|
|
2023
Q3 | $214K | Buy |
+598
| New | +$214K | 0.02% | 586 |
|
|
2020
Q3 | – | Sell |
-738
| Closed | -$333K | – | 608 |
|
|
2020
Q2 | $333K | Buy |
+738
| New | +$333K | 0.02% | 424 |
|
|
2017
Q4 | – | Sell |
-1,832
| Closed | -$407K | – | 1243 |
|
|
2017
Q3 | $407K | Sell |
1,832
-794
| -30% | -$176K | 0.01% | 898 |
|
|
2017
Q2 | $594K | Sell |
2,626
-874
| -25% | -$198K | 0.02% | 714 |
|
|
2017
Q1 | $698K | Sell |
3,500
-226
| -6% | -$45.1K | 0.02% | 656 |
|
|
2016
Q4 | $679K | Sell |
3,726
-201
| -5% | -$36.6K | 0.02% | 653 |
|
|
2016
Q3 | $643K | Sell |
3,927
-483
| -11% | -$79.1K | 0.03% | 537 |
|
|
2016
Q2 | $631K | Sell |
4,410
-335
| -7% | -$47.9K | 0.03% | 510 |
|
|
2016
Q1 | $649K | Sell |
4,745
-18
| -0.4% | -$2.46K | 0.03% | 504 |
|
|
2015
Q4 | $660K | Sell |
4,763
-500
| -10% | -$69.3K | 0.03% | 469 |
|
|
2015
Q3 | $707K | Sell |
5,263
-83
| -2% | -$11.1K | 0.06% | 348 |
|
|
2015
Q2 | $805K | Sell |
5,346
-1,954
| -27% | -$294K | 0.04% | 400 |
|
|
2015
Q1 | $993K | Sell |
7,300
-421
| -5% | -$57.3K | 0.02% | 605 |
|
|
2014
Q4 | $931K | Sell |
7,721
-22
| -0.3% | -$2.65K | 0.06% | 326 |
|
|
2014
Q3 | $878K | Sell |
7,743
-279
| -3% | -$31.6K | 0.06% | 364 |
|
|
2014
Q2 | $960K | Buy |
8,022
+2
| +0% | +$239 | 0.06% | 341 |
|
|
2014
Q1 | $1.03M | Sell |
8,020
-33
| -0.4% | -$4.23K | 0.09% | 242 |
|
|
2013
Q4 | $995K | Sell |
8,053
-219
| -3% | -$27.1K | 0.1% | 198 |
|
|
2013
Q3 | $972K | Buy |
8,272
+20
| +0.2% | +$2.35K | 0.11% | 167 |
|
|
2013
Q2 | $926K | Buy |
+8,252
| New | +$926K | 0.12% | 162 |
|